Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : VD's Model Portfolio & Discussion Thread -- Ignore unavailable to you. Want to Upgrade?

To: Cytokine1 who wrote (3683)	12/8/1997 2:24:00 PM
From: Andrew H	Respond to of 9719

Looks good, although there is no definition of "tumor response." However, it sounds very encouraging and immunotherapy is an extrememly interesting method of fighting disease. If you can stimulate the patient's own immune system to fight the disease, you avoid all the toxicity and side effects of chemical compounds. You are really using millions of years of evolutionary experiments to treat the disease.Sounds similar to a couple of CYTO's treatments, like ALT. However, this sort of treatment is slow and expensive, since it requires isolating and stimulating each patient's immune cells and then reinjecting them into the body. It is also interesting that this project is outside the bounds of transgenics.